• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

西班牙侵袭性肺炎球菌疾病新出现的血清型22F和33F的临床相关性及分子发病机制

Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of in Spain.

作者信息

Sempere Julio, de Miguel Sara, González-Camacho Fernando, Yuste José, Domenech Mirian

机构信息

Centro Nacional de Microbiología, Instituto de Salud Carlos III, Madrid, Spain.

Servicio de Epidemiología de la Comunidad de Madrid, Dirección General de Salud Pública, Madrid, Spain.

出版信息

Front Microbiol. 2020 Feb 27;11:309. doi: 10.3389/fmicb.2020.00309. eCollection 2020.

DOI:10.3389/fmicb.2020.00309
PMID:32174903
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7056674/
Abstract

is the main bacterial cause of respiratory infections in children and the elderly worldwide. Serotype replacement is a frequent phenomenon after the introduction of conjugated vaccines, with emerging serotypes 22F and 33F as frequent non-PCV13 serotypes in children and adults in North America and other countries. Characterization of mechanisms involved in evasion of the host immune response by these serotypes is of great importance in public health because they are included in the future conjugated vaccines PCV15 and PCV20. One of the main strategies of to persistently colonize and causes infection is biofilm formation. In this study, we have evaluated the influence of capsule polysaccharide in biofilm formation and immune evasion by using clinical isolates from different sources and isogenic strains with capsules from prevalent serotypes. Since the introduction of PCV13 in Spain in the year 2010, isolates of serotypes 22F and 33F are rising among risk populations. The predominant circulating genotypes are ST433 and ST717 , being CC433 in 22F and CC717 in 33F the main clonal complexes in Spain. The use of clinical isolates of different origin, demonstrated that pediatric isolates of serotypes 22F and 33F formed better biofilms than adult isolates and this was statistically significant. This phenotype was greater in clinical isolates from blood origin compared to those from cerebrospinal fluid, pleural fluid and otitis. Opsonophagocytosis assays showed that serotype 22F and 33F were recognized by the PSGL-1 receptor on leukocytes, although serotype 22F, was more resistant than serotype 33F to phagocytosis killing and more lethal in a mouse sepsis model. Overall, the emergence of additional PCV15 serotypes, especially 22F, could be associated to an enhanced ability to divert the host immune response that markedly increased in a biofilm state. Our findings demonstrate that pediatric isolates of 22F and 33F, that form better biofilm than isolates from adults, could have an advantage to colonize the nasopharynx of children and therefore, be important in carriage and subsequent dissemination to the elderly. The increased ability of serotype 22F to avoid the host immune response, might explain the emergence of this serotype in the last years.

摘要

是全球儿童和老年人呼吸道感染的主要细菌病因。引入结合疫苗后血清型替换是一种常见现象,在北美和其他国家,新出现的血清型22F和33F是儿童和成人中常见的非PCV13血清型。了解这些血清型逃避宿主免疫反应的机制对于公共卫生至关重要,因为它们被纳入了未来的结合疫苗PCV15和PCV20。持续定植并引发感染的主要策略之一是生物膜形成。在本研究中,我们通过使用来自不同来源的临床分离株以及具有流行血清型荚膜的同基因菌株,评估了荚膜多糖对生物膜形成和免疫逃避的影响。自2010年西班牙引入PCV13以来,血清型22F和33F的分离株在高危人群中呈上升趋势。主要的循环基因型是ST433和ST717,在西班牙,22F中的CC433和33F中的CC717是主要的克隆复合体。使用不同来源的临床分离株表明,血清型22F和33F的儿科分离株比成人分离株形成更好的生物膜,且具有统计学意义。与来自脑脊液、胸水和中耳炎的临床分离株相比,来自血液的临床分离株的这种表型更明显。调理吞噬试验表明,血清型22F和33F可被白细胞上的PSGL-1受体识别,尽管血清型22F比血清型33F对吞噬杀伤更具抗性,并且在小鼠败血症模型中更具致死性。总体而言,额外的PCV15血清型,尤其是22F的出现,可能与转移宿主免疫反应的能力增强有关,这种能力在生物膜状态下显著增加。我们的研究结果表明,血清型22F和33F的儿科分离株比成人分离株形成更好的生物膜,可能在定植儿童鼻咽部方面具有优势,因此在携带以及随后传播给老年人方面具有重要意义。血清型22F逃避宿主免疫反应的能力增强,可能解释了该血清型在过去几年中的出现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b110/7056674/f5569b2fd585/fmicb-11-00309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b110/7056674/69fe1a8ff5b0/fmicb-11-00309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b110/7056674/f5569b2fd585/fmicb-11-00309-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b110/7056674/69fe1a8ff5b0/fmicb-11-00309-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b110/7056674/f5569b2fd585/fmicb-11-00309-g003.jpg

相似文献

1
Clinical Relevance and Molecular Pathogenesis of the Emerging Serotypes 22F and 33F of in Spain.西班牙侵袭性肺炎球菌疾病新出现的血清型22F和33F的临床相关性及分子发病机制
Front Microbiol. 2020 Feb 27;11:309. doi: 10.3389/fmicb.2020.00309. eCollection 2020.
2
Invasive pneumococcal disease due to 22F and 33F in England: A tail of two serotypes.英格兰 22F 和 33F 导致的侵袭性肺炎球菌病:两种血清型的故事。
Vaccine. 2021 Apr 1;39(14):1997-2004. doi: 10.1016/j.vaccine.2021.02.026. Epub 2021 Mar 11.
3
Whole genome characterization of Streptococcus pneumoniae from respiratory and blood cultures collected from Canadian hospitals before and after PCV-13 implementation in Canada: Focus on serotypes 22F and 33F from CANWARD 2007-2018.对加拿大实施 PCV-13 前后加拿大医院呼吸道和血液培养中分离的肺炎链球菌进行全基因组特征分析:来自 CANWARD 2007-2018 的 22F 和 33F 血清型关注。
Vaccine. 2021 Sep 15;39(39):5474-5483. doi: 10.1016/j.vaccine.2021.08.061. Epub 2021 Aug 25.
4
Invasive Streptococcus pneumoniae in Canada, 2011-2014: Characterization of new candidate 15-valent pneumococcal conjugate vaccine serotypes 22F and 33F.2011 - 2014年加拿大侵袭性肺炎链球菌:新型15价肺炎球菌结合疫苗血清型22F和33F的特征分析
Vaccine. 2016 May 17;34(23):2527-30. doi: 10.1016/j.vaccine.2016.03.058. Epub 2016 Apr 13.
5
PCR-based discrimination of emerging Streptococcus pneumoniae serotypes 22F and 33F.基于聚合酶链反应(PCR)对新出现的肺炎链球菌22F和33F血清型的鉴别
J Microbiol Methods. 2018 Jan;144:99-106. doi: 10.1016/j.mimet.2017.11.017. Epub 2017 Nov 21.
6
Immunogenicity and protective efficacy of monovalent PCVs containing 22F and 33F polysaccharides in mouse models of colonization and co-infection.22F 和 33F 多糖单价 PCV 在定植和混合感染小鼠模型中的免疫原性和保护效力。
Vaccine. 2018 Sep 11;36(38):5701-5708. doi: 10.1016/j.vaccine.2018.08.017. Epub 2018 Aug 11.
7
Invasive pneumococcal disease caused by serotypes 22F and 33F in Canada: the SAVE study 2011-2018.加拿大 22F 和 33F 血清型导致的侵袭性肺炎球菌病:SAVE 研究 2011-2018。
Diagn Microbiol Infect Dis. 2021 Oct;101(2):115447. doi: 10.1016/j.diagmicrobio.2021.115447. Epub 2021 Jun 4.
8
Characterization of isolates obtained from the middle ear fluid of US children, 2011-2021.2011 - 2021年从美国儿童中耳液中分离出的菌株特征分析。
Front Pediatr. 2024 Jul 15;12:1383748. doi: 10.3389/fped.2024.1383748. eCollection 2024.
9
Assessment of multidrug resistance, clonality and virulence in non-PCV-13 Streptococcus pneumoniae serotypes in Canada, 2011-13.2011-2013 年加拿大非 13 价肺炎球菌结合疫苗(PCV-13)血清型肺炎链球菌的多重耐药性、克隆性和毒力评估。
J Antimicrob Chemother. 2015 Jul;70(7):1960-4. doi: 10.1093/jac/dkv061. Epub 2015 Mar 11.
10
Population structure and drug resistance patterns of emerging non-PCV-13 Streptococcus pneumoniae serotypes 22F, 15A, and 8 isolated from adults in Ontario, Canada.从加拿大安大略省成年人中分离出的新型非13价肺炎链球菌血清型22F、15A和8的群体结构及耐药模式
Infect Genet Evol. 2016 Aug;42:1-8. doi: 10.1016/j.meegid.2016.04.007. Epub 2016 Apr 9.

引用本文的文献

1
Population structure, antibiotic resistance and molecular characteristics of causing invasive disease in Hubei, China.中国湖北地区引起侵袭性疾病的病原菌的种群结构、抗生素耐药性及分子特征
J Med Microbiol. 2025 May;74(5). doi: 10.1099/jmm.0.002015.
2
PCV13 vaccine prevents pneumococcal biofilms without affecting population within the polymicrobial biofilm.PCV13 疫苗可预防肺炎球菌生物膜,而不影响多微生物生物膜中的群体。
Front Immunol. 2024 Nov 1;15:1495932. doi: 10.3389/fimmu.2024.1495932. eCollection 2024.
3
Invasive disease caused simultaneously by two different serotypes of Streptococcus pneumoniae: a microbiological appreciation.

本文引用的文献

1
Otitis media pathogens - A life entrapped in biofilm communities.中耳炎性疾病病原体——被困在生物膜群落中的生命。
Crit Rev Microbiol. 2019 Sep-Nov;45(5-6):595-612. doi: 10.1080/1040841X.2019.1660616. Epub 2019 Sep 10.
2
Phase 1 trial of a 20-valent pneumococcal conjugate vaccine in healthy adults.20 价肺炎球菌结合疫苗在健康成年人中的 1 期临床试验。
Vaccine. 2019 Sep 30;37(42):6201-6207. doi: 10.1016/j.vaccine.2019.08.048. Epub 2019 Sep 5.
3
Early Signals of Vaccine-driven Perturbation Seen in Pneumococcal Carriage Population Genomic Data.
两种不同血清型肺炎链球菌同时引起侵袭性疾病:微生物学评价。
Eur J Clin Microbiol Infect Dis. 2024 May;43(5):1013-1016. doi: 10.1007/s10096-024-04787-x. Epub 2024 Feb 28.
4
[The new 15-valent pneumococcal conjugate vaccine for the prevention of infections in pediatric age: a Health Technology Assessment].[用于预防儿童期感染的新型15价肺炎球菌结合疫苗:一项卫生技术评估]
J Prev Med Hyg. 2023 Jun 29;64(1 Suppl 1):E1-E160. doi: 10.15167/2421-4248/jpmh2023.64.1s1. eCollection 2023 Mar.
5
Enzybiotic-mediated antimicrobial functionalization of polyhydroxyalkanoates.酶促介导的聚羟基脂肪酸酯抗菌功能化
Front Bioeng Biotechnol. 2023 Jun 28;11:1220336. doi: 10.3389/fbioe.2023.1220336. eCollection 2023.
6
Non-capsular based immunization approaches to prevent infection.基于非囊膜的免疫接种方法预防感染。
Front Cell Infect Microbiol. 2022 Sep 26;12:949469. doi: 10.3389/fcimb.2022.949469. eCollection 2022.
7
Prevalence, Antimicrobial Resistance, and Associated Factors of Colonization Rate among Old-Age Patients with Respiratory Tract Infection Attending Sheik Hassan Yebere Referral and Karamara General Hospitals, Jigjiga, Ethiopia.埃塞俄比亚吉吉加市谢赫·哈桑·耶贝雷转诊医院和卡拉马拉综合医院老年呼吸道感染患者的定植率、抗菌药物耐药性及相关因素
Can J Infect Dis Med Microbiol. 2022 Sep 23;2022:9338251. doi: 10.1155/2022/9338251. eCollection 2022.
8
Clearance of mixed biofilms of Streptococcus pneumoniae and methicillin-susceptible/resistant Staphylococcus aureus by antioxidants N-acetyl-L-cysteine and cysteamine.抗氧化剂 N-乙酰-L-半胱氨酸和半胱胺清除肺炎链球菌和耐甲氧西林/敏感金黄色葡萄球菌混合生物膜。
Sci Rep. 2022 Apr 23;12(1):6668. doi: 10.1038/s41598-022-10609-x.
9
Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.2013 年至 2015 年和 2017 年至 2019 年系统引入 PCV13 之前和之后,加泰罗尼亚儿童和成人侵袭性肺炎球菌病(IPD)的肺炎链球菌分离株血清型和克隆组成。
Microbiol Spectr. 2021 Dec 22;9(3):e0115021. doi: 10.1128/Spectrum.01150-21. Epub 2021 Dec 8.
10
: a Plethora of Temperate Bacteriophages With a Role in Host Genome Rearrangement.大量温和噬菌体在宿主基因组重排中发挥作用。
Front Cell Infect Microbiol. 2021 Nov 18;11:775402. doi: 10.3389/fcimb.2021.775402. eCollection 2021.
在肺炎球菌携带人群基因组数据中发现疫苗驱动扰动的早期信号。
Clin Infect Dis. 2020 Mar 17;70(7):1294-1303. doi: 10.1093/cid/ciz404.
4
Efficacy of Aminomethyl Spectinomycins against Complex Upper Respiratory Tract Bacterial Infections.氨甲基四环素治疗复杂上呼吸道细菌感染的疗效。
Antimicrob Agents Chemother. 2019 Apr 25;63(5). doi: 10.1128/AAC.02096-18. Print 2019 May.
5
Making sense of differences in pneumococcal serotype replacement.解析肺炎球菌血清型替换中的差异。
Lancet Infect Dis. 2019 Jun;19(6):e213-e220. doi: 10.1016/S1473-3099(18)30660-1. Epub 2019 Jan 29.
6
Pneumococcal Colonization in Healthy Adult Research Participants in the Conjugate Vaccine Era, United Kingdom, 2010-2017.2010-2017 年英国结合疫苗时代健康成年研究参与者中的肺炎球菌定植。
J Infect Dis. 2019 May 24;219(12):1989-1993. doi: 10.1093/infdis/jiz034.
7
Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV-15) compared to PCV-13 in healthy older adults.15 价肺炎球菌结合疫苗(PCV-15)在健康老年人中的安全性和免疫原性与 PCV-13 的比较。
Hum Vaccin Immunother. 2019;15(3):530-539. doi: 10.1080/21645515.2018.1532249. Epub 2019 Jan 16.
8
Combination of Antibodies and Antibiotics as a Promising Strategy Against Multidrug-Resistant Pathogens of the Respiratory Tract.抗体和抗生素联合使用作为一种有前途的策略,用于对抗呼吸道的多药耐药病原体。
Front Immunol. 2018 Nov 20;9:2700. doi: 10.3389/fimmu.2018.02700. eCollection 2018.
9
Expansion of the multidrug-resistant clonal complex 320 among invasive Streptococcus pneumoniae serotype 19A after the introduction of a ten-valent pneumococcal conjugate vaccine in Brazil.巴西十价肺炎球菌结合疫苗引入后,19A 型侵袭性肺炎链球菌中耐药克隆复合体 320 的扩展。
PLoS One. 2018 Nov 29;13(11):e0208211. doi: 10.1371/journal.pone.0208211. eCollection 2018.
10
Global emergence and population dynamics of divergent serotype 3 CC180 pneumococci.血清型 3 CC180 肺炎球菌在全球的出现和种群动态。
PLoS Pathog. 2018 Nov 26;14(11):e1007438. doi: 10.1371/journal.ppat.1007438. eCollection 2018 Nov.